151 related articles for article (PubMed ID: 30241804)
1. Glutathione responsive chitosan-thiolated dextran conjugated miR-145 nanoparticles targeted with AS1411 aptamer for cancer treatment.
Tekie FSM; Soleimani M; Zakerian A; Dinarvand M; Amini M; Dinarvand R; Arefian E; Atyabi F
Carbohydr Polym; 2018 Dec; 201():131-140. PubMed ID: 30241804
[TBL] [Abstract][Full Text] [Related]
2. Nano polyelectrolyte complexes of carboxymethyl dextran and chitosan to improve chitosan-mediated delivery of miR-145.
Tekie FS; Kiani M; Zakerian A; Pilevarian F; Assali A; Soleimani M; Dinarvand R; Arefian E; Atashi A; Amini M; Atyabi F
Carbohydr Polym; 2017 Mar; 159():66-75. PubMed ID: 28038755
[TBL] [Abstract][Full Text] [Related]
3. Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.
Saravanakumar K; Sathiyaseelan A; Mariadoss AVA; Jeevithan E; Hu X; Shin S; Wang MH
Carbohydr Polym; 2020 Oct; 245():116407. PubMed ID: 32718591
[TBL] [Abstract][Full Text] [Related]
4. Thiolated carboxymethyl dextran as a nanocarrier for colon delivery of hSET1 antisense: In vitro stability and efficiency study.
Kiani M; Mirzazadeh Tekie FS; Dinarvand M; Soleimani M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():771-8. PubMed ID: 26952483
[TBL] [Abstract][Full Text] [Related]
5. AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Nanomedicine (Lond); 2018 Nov; 13(21):2729-2758. PubMed ID: 30394201
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Kaban K; Salva E; Akbuga J
Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825
[TBL] [Abstract][Full Text] [Related]
8. Chitosan based copolymer-drug conjugate and its protein targeted polyelectrolyte complex nanoparticles to enhance the efficiency and specificity of low potency anticancer agent.
Sutar YB; Telvekar VN
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():393-406. PubMed ID: 30184765
[TBL] [Abstract][Full Text] [Related]
9. Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas.
Ghasemi Z; Dinarvand R; Mottaghitalab F; Esfandyari-Manesh M; Sayari E; Atyabi F
Carbohydr Polym; 2015 May; 121():190-8. PubMed ID: 25659689
[TBL] [Abstract][Full Text] [Related]
10. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
[TBL] [Abstract][Full Text] [Related]
11. Chitosan/carbon quantum dot/aptamer complex as a potential anticancer drug delivery system towards the release of 5-fluorouracil.
Zavareh HS; Pourmadadi M; Moradi A; Yazdian F; Omidi M
Int J Biol Macromol; 2020 Dec; 165(Pt A):1422-1430. PubMed ID: 32987067
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
Kardani A; Yaghoobi H; Alibakhshi A; Khatami M
J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016
[TBL] [Abstract][Full Text] [Related]
13. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle.
Kim JK; Choi KJ; Lee M; Jo MH; Kim S
Biomaterials; 2012 Jan; 33(1):207-17. PubMed ID: 21944470
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery.
Alibolandi M; Mohammadi M; Taghdisi SM; Ramezani M; Abnous K
Carbohydr Polym; 2017 Jan; 155():218-229. PubMed ID: 27702507
[TBL] [Abstract][Full Text] [Related]
16. AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.
Kong T; Zhou R; Zhang Y; Hao L; Cai X; Zhu B
Cell Prolif; 2020 Jan; 53(1):e12713. PubMed ID: 31691382
[TBL] [Abstract][Full Text] [Related]
17. Formation and characterization of polyelectrolyte complex synthesized by chitosan and carboxylic curdlan for 5-fluorouracil delivery.
Yan JK; Qiu WY; Wang YY; Wu LX; Cheung PCK
Int J Biol Macromol; 2018 Feb; 107(Pt A):397-405. PubMed ID: 28882758
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
Esfandyari-Manesh M; Mohammadi A; Atyabi F; Nabavi SM; Ebrahimi SM; Shahmoradi E; Varnamkhasti BS; Ghahremani MH; Dinarvand R
Int J Pharm; 2016 Dec; 515(1-2):607-615. PubMed ID: 27989825
[TBL] [Abstract][Full Text] [Related]
19. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.
Bisht S; Maitra A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):415-25. PubMed ID: 20049807
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
